Logo

Marcus Schabacker

Dec 27, 2017

Marcus Schabacker, a board-certified anesthesiologist and intensivist, has been named CEO and president of ECRI Institute, a health services research organization with an interest in genetic testing. Schabacker, who has 18 years of leadership experience in the medical device and pharmaceutical industries, recently served as chief scientific officer of Baxter. He previously helped Nelson Mandela rebuild South Africa's rural health system in the post-Apartheid era. Schabaker will replace Jeffrey Lerner, who is retiring Dec. 31 after 16 years as ECRI president and CEO.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.